The Ministry of Health has prepared amendments to the List of medicines and medical products for free and preferential outpatient provision of certain categories of citizens of the Republic of Kazakhstan with certain diseases (conditions).
Thus, the list of outpatient drug provision includes the drugs "Amisulpride", "Perindopril" in combination with diuretics, "Guselkumab", "Apalutamide" and "Daratumumab".
In particular, they are applied:
"Amisulpride" is an antipsychotic drug used in the treatment of schizophrenia and other mental disorders;
"Perindopril" in combination with diuretics is a drug for the treatment of arterial hypertension and cardiovascular diseases;
"Guselkumab" is a drug used to treat psoriasis;
"Apalutamide" is a drug used in the treatment of oncological diseases;
"Daratumumab" is a drug for the treatment of malignant diseases.
As explained by the Ministry of Health, the inclusion of these drugs in the list of outpatient drug provision will allow patients to receive them free of charge, which is especially important for people with chronic diseases.
"The measures taken are aimed at ensuring the availability of high-quality medical care and improving the health of the population," the rationale states.
The document is posted on the website "Open NPA" for public discussion until March 1 at the link: https://legalacts.egov.kz/npa/view?id=15459858
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
Thus, the list of outpatient drug provision includes the drugs "Amisulpride", "Perindopril" in combination with diuretics, "Guselkumab", "Apalutamide" and "Daratumumab".
In particular, they are applied:
"Amisulpride" is an antipsychotic drug used in the treatment of schizophrenia and other mental disorders;
"Perindopril" in combination with diuretics is a drug for the treatment of arterial hypertension and cardiovascular diseases;
"Guselkumab" is a drug used to treat psoriasis;
"Apalutamide" is a drug used in the treatment of oncological diseases;
"Daratumumab" is a drug for the treatment of malignant diseases.
As explained by the Ministry of Health, the inclusion of these drugs in the list of outpatient drug provision will allow patients to receive them free of charge, which is especially important for people with chronic diseases.
"The measures taken are aimed at ensuring the availability of high-quality medical care and improving the health of the population," the rationale states.
The document is posted on the website "Open NPA" for public discussion until March 1 at the link: https://legalacts.egov.kz/npa/view?id=15459858
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
